Related Articles
Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain
Monocyte chemoattractant protein‑1 contributes to morphine tolerance in rats with cancer‑induced bone pain
YY1 promotes SOCS3 expression to inhibit STAT3‑mediated neuroinflammation and neuropathic pain
Role of nitric oxide synthase in the development of bone cancer pain and effect of L‑NMMA
Complement factor C5a and C5a receptor contribute to morphine tolerance and withdrawal-induced hyperalgesia in rats